Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Waters (WAT) Share Price

Media headlines about Waters (NYSE:WAT) have trended somewhat positive on Tuesday, according to Accern. The research firm ranks the sentiment of media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Waters earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned news headlines about the medical instruments supplier an impact score of 45.354322613868 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

These are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

A number of research analysts recently weighed in on WAT shares. Zacks Investment Research raised Waters from a “hold” rating to a “buy” rating and set a $211.00 price objective on the stock in a research note on Monday, October 23rd. Morgan Stanley raised Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 price objective on the stock in a research note on Monday, December 4th. Barclays raised their price objective on Waters from $188.00 to $193.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 25th. Deutsche Bank raised their price objective on Waters from $199.00 to $200.00 and gave the company a “hold” rating in a research note on Wednesday, October 25th. Finally, Cowen reissued a “hold” rating and issued a $190.00 price objective on shares of Waters in a research note on Friday, November 3rd. One analyst has rated the stock with a sell rating, nine have given a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. Waters has an average rating of “Hold” and an average price target of $194.08.

Shares of Waters (NYSE WAT) traded up $0.03 during midday trading on Tuesday, reaching $193.82. The company’s stock had a trading volume of 116,828 shares, compared to its average volume of 509,380. The company has a current ratio of 6.16, a quick ratio of 5.71 and a debt-to-equity ratio of 0.66. The company has a market cap of $15,412.70, a P/E ratio of 28.59, a P/E/G ratio of 2.81 and a beta of 0.82. Waters has a 52 week low of $133.71 and a 52 week high of $201.95.

Waters (NYSE:WAT) last issued its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.03. The company had revenue of $565.58 million for the quarter, compared to the consensus estimate of $555.25 million. Waters had a return on equity of 23.61% and a net margin of 24.34%. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.57 EPS. sell-side analysts expect that Waters will post 7.42 earnings per share for the current year.

In other news, SVP Rohit Khanna sold 26,913 shares of Waters stock in a transaction that occurred on Friday, October 27th. The stock was sold at an average price of $197.93, for a total transaction of $5,326,890.09. Following the sale, the senior vice president now owns 13,677 shares of the company’s stock, valued at approximately $2,707,088.61. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William J. Miller sold 3,500 shares of Waters stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $194.94, for a total value of $682,290.00. Following the sale, the director now directly owns 25,849 shares in the company, valued at approximately $5,039,004.06. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 91,773 shares of company stock worth $18,143,191. Company insiders own 5.07% of the company’s stock.

WARNING: This article was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://www.com-unik.info/2017/12/26/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-waters-wat-share-price.html.

About Waters

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Insider Buying and Selling by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit